Syndax Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidate includes Revuforj (revumenib), a menin inhibitor ...
The EU's Anti-Coercion Instrument could limit access to public tenders in the bloc or restrict trade in services in which the U.S. has a surplus with the EU. A draft charter sent to about 60 countries ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback